BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37641643)

  • 1. Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling.
    Khattab AAA; Ahmed MM; Hammed AH
    Med Hypothesis Discov Innov Ophthalmol; 2022; 11(3):110-118. PubMed ID: 37641643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anatomical and functional outcomes of vitrectomy with internal limiting membrane peeling in recalcitrant diabetic macular edema with and without traction in Indian patients.
    Vikas SJ; Agarwal D; Seth S; Kumar A; Kumar A
    Indian J Ophthalmol; 2021 Nov; 69(11):3297-3301. PubMed ID: 34708792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Macular Changes in the Long Term after Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Diabetic Macular Edema.
    Gunay BO; Erdogan G
    Ophthalmologica; 2021; 244(3):237-244. PubMed ID: 33540415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Horozoglu F; Celik E; Nohutcu AF
    Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.
    Ranno S; Vujosevic S; Mambretti M; Metrangolo C; Alkabes M; Rabbiolo G; Govetto A; Carini E; Nucci P; Radice P
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pars plana vitrectomy with internal limiting membrane peeling for refractory diffuse diabetic macular edema.
    Dehghan MH; Salehipour M; Naghib J; Babaeian M; Karimi S; Yaseri M
    J Ophthalmic Vis Res; 2010 Jul; 5(3):162-7. PubMed ID: 22737351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane.
    Ghassemi F; Bazvand F; Roohipoor R; Yaseri M; Hassanpoor N; Zarei M
    J Curr Ophthalmol; 2016 Dec; 28(4):199-205. PubMed ID: 27830204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrectomy for diabetic macular edema and the relevance of external limiting membrane.
    Ivastinovic D; Haas A; Weger M; Seidel G; Mayer-Xanthaki C; Lindner E; Guttmann A; Wedrich A
    BMC Ophthalmol; 2021 Sep; 21(1):334. PubMed ID: 34525998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Nohutcu AF; Horozoglu F; Celik E
    Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.
    Iglicki M; Lavaque A; Ozimek M; Negri HP; Okada M; Chhablani J; Busch C; Loewenstein A; Zur D
    PLoS One; 2018; 13(7):e0200365. PubMed ID: 29995929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.
    Bahadir M; Ertan A; Mertoğlu O
    Int Ophthalmol; 2005; 26(1-2):3-8. PubMed ID: 16786177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
    Rosenblatt BJ; Shah GK; Sharma S; Bakal J
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):20-5. PubMed ID: 15290152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
    Ando F; Yasui O; Hirose H; Ohba N
    Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTERNAL LIMITING MEMBRANE PEELING VERSUS INVERTED FLAP TECHNIQUE FOR TREATMENT OF FULL-THICKNESS MACULAR HOLES: A COMPARATIVE STUDY IN A LARGE SERIES OF PATIENTS.
    Rizzo S; Tartaro R; Barca F; Caporossi T; Bacherini D; Giansanti F
    Retina; 2018 Sep; 38 Suppl 1():S73-S78. PubMed ID: 29232338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study.
    Rush RB; Rush SW
    Clin Ophthalmol; 2021; 15():2619-2624. PubMed ID: 34188440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subfoveal choroidal thickness following pars plana vitrectomy in tractional diabetic macular edema.
    Dourandeesh M; Moeini M; Shaye ZA; Shoeibi N; Hosseini SM; Banaee T
    Eur J Ophthalmol; 2023 May; 33(3):1405-1411. PubMed ID: 36476066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitrectomy With Epiretinal Membrane Peeling Alone Verses Combined With Internal Limiting Membrane Peeling For Idiopathic Epiretinal Membrane.
    Jatoi A; Shaikh FF; Rehman AU
    J Ayub Med Coll Abbottabad; 2020; 32(4):450-453. PubMed ID: 33225642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILM peeling in nontractional diabetic macular edema: review and metanalysis.
    Rinaldi M; dell'Omo R; Morescalchi F; Semeraro F; Gambicorti E; Cacciatore F; Chiosi F; Costagliola C
    Int Ophthalmol; 2018 Dec; 38(6):2709-2714. PubMed ID: 29090356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fovea-Sparing versus Standard Internal Limiting Membrane Peeling for Myopic Traction Maculopathy: A Study of 102 Consecutive Cases.
    Shiraki N; Wakabayashi T; Ikuno Y; Matsumura N; Sato S; Sakaguchi H; Nishida K
    Ophthalmol Retina; 2020 Dec; 4(12):1170-1180. PubMed ID: 32470651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.